Answers are grounded in this paper and cite their sources.
The aim of our study was to ascertain whether the specific Bifidobacterium animalis DN-173 010 fermented milk could modulate colonic transit time in humans. Bifidobacteria are a major component of the gut microflora and may interact with gut transit. Methods: The trial compared in a parallel double blind study in seventy two healthy volunteers the effect of a Bifidobacterium animalis fermented milk containing 2.6×108 CFU/g living bifidobacteria versus heat-treated Bifidobacterium fermented milk on colonic transit times. The main marker was the total colonic transit time (CTT) measured with radio-opaque pellets. Segmental colonic transit times were also calculated. Results: A 11-day-consumption of this Bifidobacterium animalis DN-173 010 fermented milk significantly reduced the total CTT (-20.6%) comparatively to the initial CTT and to the control group where no significant change were recorded. The effect was more pronounced in women than in men. Conclusion: Our study demonstrated that the consumption of the fermented milk containing living Bifidobacterium animalis DN-173 010 was able to improve CTT in humans.
No takes yet. Share an insight, caveat, or question.
Bouvier et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: